Daniel Nomura

Daniel Nomura has a diverse work experience in the fields of venture capital, pharmaceuticals, academia, and research. Daniel currently serves as an Advisory Partner at Andreessen Horowitz, providing expertise and guidance in investment decisions. Prior to that, they were a member of the Investment Advisory Board at Droia Ventures. Daniel is also the Founder, Scientific Adviser, and Board Member of Vicinitas Therapeutics, a biotech company.

In terms of academia, Nomura has held various positions at the University of California, Berkeley, starting as an Assistant Professor and eventually becoming a Professor of Chemical Biology and Molecular Therapeutics. Daniel has also served as an Associate Adjunct Professor at UCSF.

Nomura has an extensive research background, including a role as a Postdoctoral Fellow at The Scripps Research Institute. Daniel also conducted research as a Graduate Student Researcher and an Undergraduate Researcher at the University of California, Berkeley.

Overall, Nomura brings a wealth of experience in venture capital, pharmaceuticals, academia, and research to their current role as an Advisory Partner at Andreessen Horowitz.

Daniel Nomura completed their education in a chronological manner, starting with their Bachelor of Arts degree in Molecular and Cell Biology from the University of California, Berkeley in 2003. Daniel then pursued further studies and obtained a Doctor of Philosophy degree in Molecular Toxicology from the same university, completing their Ph.D. in 2008.